Skip to content

Search

Showing results for "early childhood"

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Acute leukemia continues to be a major cause of death from disease worldwide and current chemotherapeutic agents are associated with significant morbidity in survivors. While better and safer treatments for acute leukemia are urgently needed, standard drug development pipelines are lengthy and drug repurposing therefore provides a promising approach.

Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease

Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of uncertain significance (VUS). Functional analysis of each VUS is required in specialised laboratories, to determine whether the VUS is disease causative or not, leading to lengthy diagnostic delays.

Characterising moment-to-moment fluctuation in stress, anxiety and blood glucose levels in adolescents with type 1 diabetes

Keely Tim Liz Bebbington Jones Davis MClinPsych/PhD MBBS DCH FRACP MD MBBS FRACP PhD McCusker Postdoctoral Research Fellow in Type 1 Diabetes Co-head

CRISPR gene editing and stem cell disease modelling: a new path to genetic and rare disease patient diagnosis

Vanessa Timo Fear Lassmann BSc (Hons), PhD BSc (Hons) MSc PhD Head, Translational Genetics Team Feilman Fellow; Head, Precision Health Research and

Developing a protocol for a national study of bullying prevalance in school-aged children

The Kids Research Institute Australia's Human Capability Team has been asked by the Commonwealth Department of Education, Skills and Employment (DESE) to prepare a methodology and project plan to conduct a nationally-representative survey of bullying prevalence among children and young people in Years 4–10.

Novel therapeutics approaches for infants with high-risk infant acute lymphoblastic leukaemia

Rishi S. Laurence Sébastien Kotecha Cheung Malinge MB ChB (Hons) MRCPCH FRACP PhD BPharm (Hons) MBA PhD PhD Co-Head, Leukaemia Translational Research

The PneuCaPTIVE study

Christopher Deborah Blyth Lehmann MBBS (Hons) DCH FRACP FRCPA PhD AO, MBBS, MSc Centre Head, Wesfarmers Centre of Vaccines and Infectious Diseases;

The Adult Migrant English Program (AMEP) Impact Evaluation Project

This project evaluates the effectiveness of the Adult Migrant English Program (AMEP). To date, we have produced five research reports submitted to the Australian Government Department of Home Affairs.

Corporate Philanthropy

How can your organisation help improve the lives of children?

When the bell rings: Inside the Undiagnosed Hackathon giving families answers

In 2026, Rare Disease Day is recognised on 28 February to raise awareness and generate change for people living with rare disease, their families and carers worldwide. This year’s global theme, More than you can imagine, highlights the immense impact of rare disease on families across the world.